Skip to main content

Clinical Trials

Implementation and Evaluation of a Formal Investigational Drug Service at a Community Cancer Center
Colton Zwart, PharmD, BCOP; Aimee Cloud, PharmD, BCOP; Amanda Kogelman, PharmD, BCOP; Claire Boomershine, PharmD, BCOP
Read More
Pyrexia Management in Patients with Melanoma Treated with Dabrafenib/Trametinib Combination Therapy
Read More
Evaluation of Clinical Pharmacy Services for Phase 1 Clinical Trials
Jacqueline Saunders, PharmD, BCPS; Sumati Murli, PhD; Michelle A. Rudek, PharmD, PhD; Anand Khandoobhai, PharmD, MS; Anne DeLisa, PharmD, CCRP; Amy Goodrich, RN, MSN, CRNP-AC; Janet Mighty, BS Pharm, MBA
Read More
Sacituzumab Govitecan Moves to Second-Line Therapy for Metastatic Triple-Negative Breast Cancer: Applying the Lessons from Clinical Trials to Clinical Practice
Read More
Meeting Highlights
Step-Up Glofitamab Dosing Induces High Response Rates in Relapsed or Refractory Non-Hodgkin Lymphoma
Read More
Delivering High-Value Personalized Interventions
Read More
Patients with Medicaid or No Insurance Have Worse Survival in Clinical Trials
Read More
Patient-Centered Clinical Pathways Should Incorporate the Patient’s Voice
Read More
Page 2 of 2
Results 11 - 18 of 18